The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance
- PMID: 23320394
- DOI: 10.1111/cmi.12108
The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance
Abstract
Ongoing human infections with highly pathogenic avian H5N1 viruses and the emergence of the pandemic swine-origin influenza viruses (IV) highlight the permanent threat elicited by these pathogens. Occurrence of resistant seasonal and pandemic strains against the currently licensed antiviral medications points to the urgent need for new and amply available anti-influenza drugs. The recently identified virus-supportive function of the cellular IKK/NF-κB signalling pathway suggests this signalling module as a potential target for antiviral intervention. We characterized the NF-κB inhibitor SC75741 as a broad and efficient blocker of IV replication in non-toxic concentrations. The underlying molecular mechanism of SC75741 action involves impaired DNA binding of the NF-κB subunit p65, resulting in reduced expression of cytokines, chemokines, and pro-apoptotic factors, subsequent inhibition of caspase activation and block of caspase-mediated nuclear export of viralribonucleoproteins. SC75741 reduces viral replication and H5N1-induced IL-6 and IP-10 expression in the lung of infected mice. Besides its virustatic effect the drug suppresses virus-induced overproduction of cytokines and chemokines, suggesting that it might prevent hypercytokinemia that is discussed to be an important pathogenicity determinant of highly pathogenic IV. Importantly the drug exhibits a high barrier for development of resistant virus variants. Thus, SC75741-derived drugs may serve as broadly non-toxic anti-influenza agents.
© 2013 John Wiley & Sons Ltd.
Similar articles
-
The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.Antiviral Res. 2013 Sep;99(3):336-44. doi: 10.1016/j.antiviral.2013.06.008. Epub 2013 Jun 28. Antiviral Res. 2013. PMID: 23811282
-
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.Cell Microbiol. 2007 Jul;9(7):1683-94. doi: 10.1111/j.1462-5822.2007.00902.x. Epub 2007 Feb 23. Cell Microbiol. 2007. PMID: 17324159
-
Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006. Epub 2011 Jul 13. Antiviral Res. 2011. PMID: 21777621
-
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.J Antimicrob Chemother. 2009 Jul;64(1):1-4. doi: 10.1093/jac/dkp161. Epub 2009 May 6. J Antimicrob Chemother. 2009. PMID: 19420020 Review.
-
[Cytokine storm in avian influenza].Mikrobiyol Bul. 2008 Apr;42(2):365-80. Mikrobiyol Bul. 2008. PMID: 18697437 Review. Turkish.
Cited by
-
Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection.PLoS Pathog. 2024 Mar 1;20(3):e1012031. doi: 10.1371/journal.ppat.1012031. eCollection 2024 Mar. PLoS Pathog. 2024. PMID: 38427950 Free PMC article.
-
Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.Antiviral Res. 2016 Sep;133:62-72. doi: 10.1016/j.antiviral.2016.07.019. Epub 2016 Jul 28. Antiviral Res. 2016. PMID: 27478032 Free PMC article.
-
Response Modifiers: Tweaking the Immune Response Against Influenza A Virus.Front Immunol. 2019 Apr 12;10:809. doi: 10.3389/fimmu.2019.00809. eCollection 2019. Front Immunol. 2019. PMID: 31031778 Free PMC article. Review.
-
The intricate interplay between RNA viruses and NF-κB.Biochim Biophys Acta. 2014 Nov;1843(11):2754-2764. doi: 10.1016/j.bbamcr.2014.08.004. Epub 2014 Aug 10. Biochim Biophys Acta. 2014. PMID: 25116307 Free PMC article. Review.
-
Human Herpesvirus 6A Tegument Protein U14 Induces NF-κB Signaling by Interacting with p65.J Virol. 2021 Nov 9;95(23):e0126921. doi: 10.1128/JVI.01269-21. Epub 2021 Sep 22. J Virol. 2021. PMID: 34549982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical